Brief: Cocrystal Pharma Reports First Quarter 2022 Financial Results
11/05/2022 13:06
May 11 (Reuters) - Cocrystal Pharma Inc COCP.O :
* COCRYSTAL PHARMA REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND PROVIDES UPDATES ON ITS ANTIVIRAL DEVELOPMENT PROGRAMS AND
MILESTONES
* COCRYSTAL PHARMA INC - NET LOSS FOR Q1 OF 2022 WAS $4.2
MILLION,
OR $0.04 PER SHARE
Source text for Eikon: ID:nGNX1prpz9
Further company coverage: COCP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cocrystal Pharma
See all newsBrief: Cocrystal Pharma Announces Last Subject Dosed In Phase 1b Human Challenge Study Evaluating CDI-988 For Norovirus Prevention And Treatment
Cocrystal Pharma Inc reports results for the quarter ended June 30 - Earnings Summary
Cocrystal Pharma Inc expected to post a loss of 16 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway